NICE issues final guidance on CKD

NICE has published final guidelines on the treatment of chronic kidney disease (CKD).

The guidelines, released in draft in March, recommend that patients with diabetes, hypertension or cardiovascular disease be offered testing for CKD.

Urine albumin-creatinine ratio should be used to detect and identify proteinuria, although protein-creatinine ratio can be used to quantify and monitor the condition.

An ACE inhibitor should be the first choice treatment for blocking the rennin-angiotensin system, moving to an angiotensin-II receptor blocker if this is not tolerated.

If management issues arise, GPs should discuss these with a specialist.

Comment below and tell us what you think

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins


Already registered?

Sign in

Before commenting please read our rules for commenting on articles.

If you see a comment you find offensive, you can flag it as inappropriate. In the top right-hand corner of an individual comment, you will see 'flag as inappropriate'. Clicking this prompts us to review the comment. For further information see our rules for commenting on articles.

comments powered by Disqus